IP Library › Granted Patent US 6,939,310
Granted Patent B2
US 6,939,310 · App. 09/974,654 · Granted Sep 6, 2005

Devices for physiological fluid sampling and methods of using the same

Assignee: LifeScan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,310
App. No.
09/974,654
Granted
Sep 6, 2005
Kind
B2
Abstract

Methods and devices are provided for determining a suitable site for sampling physiological fluid. In the subject methods, a potentially suitable physiological sampling site is selected, the fluid flow of the site is characterized and the site is then determined to be suitable based on the whether the site has high or low flow. Suitability may also be determined based on the type of sample obtainable from the site, where the order of the above-described steps may be altered. The subject devices include at least one site flow characterization element for determining the flow characteristics of a potential physiological sampling site and/or at least one sample type characterization element for determining whether the vasculature is arterial, venous or neither, i.e., an interstitial fluid sampling site. The subject methods and devices are particularly suited for use in the detection of physiological sampling sites in the fingers, arms, legs, earlobes, heels, feet, nose and toes. Also provided are kits that include the subject devices for use in practicing the subject methods.

Claims (133)

1. A device for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said device comprising:

at least one physiological fluid flow rate characterization element for measuring the flow rate of physiological fluid at said site;

at least one skin-piercing element for accessing said physiological fluid at said site; and means for determining whether said site is suitable for sampling physiological fluid for use in said analyte concentration determination test based on said measured flow rate of physiological fluid at said site.

2. The device according to claim 1 , wherein said at least one physiological fluid flow rate characterization element comprises an element capable of determining the temperature of said physiological fluid at said site.

3. The device according to claim 1 , wherein said at least one physiological fluid flow rate characterization element comprises an element capable of determining red blood cell character of said physiological fluid at said site.

4. The device according to claim 1 , wherein said at least one physiological fluid flow rate characterization element comprises at least one light so for irradiating tissue with light and at least one detector for detecting the light absorbed by said tissue.

5. The device according to claim 4 , wherein at least one light so is capable of emitting light at a wavelength in the range from about 400 nm to 1200 nm.

6. The device according to claim 1 , wherein said at least one flow characterization element comprises an element capable of performing Doppler flowmetry.

7. The device according to claim 1 , further comprising at least one physiological fluid sample type characterization element.

8. The device according to claim 1 , further comprising an analyte concentration determination reagent test strip.

9. The device according to claim 8 , wherein said test strip is an electrochemical test strip.

10. The device according to claim 8 , wherein said test strip is a colorimetric test strip.

11. The device according to claim 1 , further comprising a means for automatically determining the concentration of at least one analyte in said physiological fluid.

12. The device according to claim 1 , further comprising at least one fluid enhancing element.

13. The device according to claim 7 , wherein said at least one physiological fluid sample type characterization element comprises a hemoglobin characterization element.

14. The device according to claim 7 , wherein said a least one physiological fluid sample type characterization element comprises a pulse characterization element.

15. A device for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said device comprising:

at least one physiological fluid sample type characterization element for determining whether a site comprises arterial fluid, venous fluid or interstitial fluid;

at least one skin-piercing element for accessing said physiological fluid at said site; and

means for determining whether said site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined fluid type.

16. The device according to claim 15 , further comprising at least one physiological fluid flow rate characterization element.

17. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises at least one light source for irradiating tissue with light and at least one detector for detecting the light absorbed by said tissue.

18. The device according to claim 17 , wherein said at least one light source is capable of emitting light at a wavelength from about 400 nm to 1200 nm.

19. The device according to claim 17 , wherein said at least one light source includes at least two light sources.

20. The device according to claim 19 , wherein each of said at least two light sources is capable of emitting light at a wavelength from about 400 nm to 1200 nm.

21. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the pulse character of said site.

22. The device according to claim 6 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the hemoglobin character of said physiological fluid at said site.

23. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the hemoglobin concentration of said physiological fluid at said site.

24. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the concentration of oxygenated hemoglobin and deoxygenated hemoglobin of said physiological fluid at said site.

25. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the concentration of total hemoglobin of said physiological fluid at said site.

26. The device according to claim 15 , wherein said a least one physiological fluid sample type characterization element comprises an element capable of determining the oxygenated hemoglobin to deoxygenated hemoglobin ratio of said physiological fluid at said site.

27. The device according to claim 16 , wherein said a least one physiological fluid flow rate characterization element comprises a hemoglobin characterization element.

28. The device according to claim 15 , further comprising an analyte concentration determination reagent test strip.

29. The device according to claim 28 , wherein said test strip is an electrochemical test strip.

30. The device according to claim 28 , wherein said test strip is a colorimetric test strip.

31. The device according to claim 15 , further comprising a means for automatically determining the concentration of at least one analyte in said physiological fluid.

32. The device according to claim 15 , further comprising at least one fluid enhancing element.

33. The device according to claim 16 , wherein said a least one physiological fluid flow rate characterization element comprises a pulse characterization element.

34. A device for determining the suitability of a site or sampling physiological fluid for use in an analyte concentration determination test, said device comprising:

at least one physiological fluid flow rate characterization element for measuring the flow rate of physiological fluid at said site;

at least one physiological fluid sample type characterization element for determining whether said site comprises arterial fluid, or venous fluid or interstitial fluid; and

means for determining whether said site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on the measured flow rate of physiological fluid at said site and based on the determined fluid type at said site.

35. The device according to claim 34 , further comprising a means for automatically determining the concentration of at least one analyte in said physiological sample.

36. The device according to claim 34 , further comprising at least one skin-piercing element.

37. The device according to claim 34 , wherein said a least one of said physiological fluid flow rate characterization element and said physiological fluid sample type characterization element comprises at least one light source and at least one detector.

38. The device according to claim 34 , wherein said a least one physiological fluid flow rate characterization element comprises a temperature characterization element.

39. The device according to claim 34 , wherein said a least one physiological fluid flow rate characterization element comprises a red blood cell characterization element.

40. The device according to claim 34 , wherein said at least one physiological fluid sample type characterization element comprises a pulse characterization element.

41. The device according to claim 34 , wherein said at least one physiological fluid sample type characterization element comprises a hemoglobin characterization element.

42. The device according to claim 34 , further comprising at least one fluid enhancing element.

43. The device according to claim 34 , further comprising an analyte concentration determination reagent test strip.

44. The device according to claim 43 , wherein said test strip is an electrochemical test strip.

45. The device according to claim 43 , wherein said test strip is a colorimetric test strip.

46. A method for determining the suitability of a site or sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

measuring the flow rate of physiological fluid at a potentially suitable site; and

determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said measured flow rate.

47. The method according to claim 46 , further comprising the step of determining the concentration of at least one analyte in said physiological sample.

48. The method according to claim 47 , wherein said at least one analyte is glucose and said physiological sample is blood.

49. The method according to claim 47 , wherein said at least one analyte is glucose and said physiological sample is interstitial fluid.

50. The method according to claim 46 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises characterizing the temperature of said physiological fluid at said potentially suitable site.

51. The method according to claim 46 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises determining the red blood cell character of said potentially suitable site.

52. The method according to claim 51 , wherein said step of determining the red blood cell character of said site comprises irradiating said potentially suitable site with light and detecting the light absorbed by said physiologically suitable site.

53. The method according to claim 51 , wherein said step of determining the red blood cell character of said site comprises characterizing the red blood cell flux of said site.

54. The method according to claim 46 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises employing Doppler flowmetry techniques.

55. The method according to claim 46 , further comprising the step of determining the type of physiological fluid at said potentially suitable site.

56. The method according to claim 46 , wherein said step of determining the type of physiological fluid at said potentially suitable site comprises characterizing the pulse of said site.

57. The method according to claim 55 , wherein said step of determining the type of physiological fluid at said potentially suitable site comprises characterizing the hemoglobin of said physiological fluid at said site.

58. The method according to claim 46 , further comprising the step of accessing said physiological fluid at said suitable sampling site.

59. The method according to claim 46 , further comprising the step of stimulating the site to enhance the volume of fluid expressed from said site.

60. The method according to claim 47 , wherein an automated meter performs said concentration determination automatically.

61. The method according to claim 47 , wherein said concentration determination comprises transferring said physiological sample to an analyte concentration test strip.

62. A kit for determining a site for sampling physiological fluid, said kit comprising:

(a) at least one device selected from the group consisting of:

i. a device according to claim 1 ,

ii. a device according to claim 15 , and

iii. a device according to claim 34 , and

(b) instructions for using said device.

63. The kit according to claim 62 , further comprising at least on skin-piercing element.

64. The kit according to claim 62 , further comprising at least one fluid stimulating element.

65. The kit according to claim 62 , further comprising at least on analyte concentration characterization reagent test strip.

66. The kit according to claim 62 , further comprising at least one meter for automatically determining the concentration of an analyte in said physiological sample.

67. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the step of:

(a) determining the type of physiological fluid at a potentially suitable site, wherein said determining comprises characterizing the pulse of said potentially suitable site; and

(b) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on determined type of physiological fluid.

68. The method according to claim 67 , wherein the step of characterizing the pulse of said site comprises characterizing the red blood cell character of said site.

69. The method according to claim 68 , wherein the step of characterizing the red blood cell character of said site comprises characterizing the red blood cell flux of said site.

70. The method according to claim 67 , further comprising the step of determining the concentration of at least one analyte in said physiological sample.

71. The method according to claim 70 , wherein said concentration determination comprises transferring said physiological sample to an analyte concentration test strip.

72. The method according to claim 70 , wherein said at least one analyte is glucose and said physiological sample is blood.

73. The method according to claim 70 , wherein said at least one analyte is glucose and said physiological sample is interstitial fluid.

74. The method according to claim 70 , wherein an automated meter performs said concentration determination automatically.

75. The method according to claim 67 , further comprising the step of stimulating the site to enhance the volume of fluid expressed from said site.

76. The method according to claim 67 , further comprising the step of accessing said physiological fluid at said suitable sampling site.

77. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

(a) determining the type of physiological fluid at a potentially suitable site, wherein said determining comprises characterizing the hemoglobin character of physiological fluid said potentially site; and

(b) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test based on said determined type of physiological fluid.

78. The method according to claim 77 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the hemoglobin concentration of said physiological fluid at said site.

79. The method according to claim 77 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the concentration of the oxygenated hemoglobin and deoxygenated hemoglobin of said physiological fluid at said site.

80. The method according to claim 77 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the oxygenated hemoglobin to deoxygenated hemoglobin ration of said physiological fluid at said site.

81. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

(a) determining the type of physiological fluid at a potentially suitable site;

(b) measuring the flow rate of physiological fluid at said potentially suitable site; and

(c) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined type and flow rate of physiological fluid.

82. The method according to claim 81 , wherein said step of measuring the flow rate of said physiological fluid at said site comprises characterizing the temperature of said physiological fluid at said site.

83. The method according to claim 81 , wherein said step of measuring the flow rate of said physiological fluid at said site comprises characterizing the red blood cell character of said site.

84. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

measuring the flow rate of physiological fluid at a potentially suitable site;

determining the type of physiological fluid of said potentially suitable site; and

determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said measured flow rate of physiological fluid and based on said determined fluid type at said site.

85. The method according to claim 84 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises determining the red blood cell character of said potentially suitable site.

86. The method according to claim 85 , wherein said step of determining the red blood cell character of said site comprises irradiating said physiological suitable site the light and detecting the light absorbed by said physiologically suitable site.

87. The method according to claim 85 , wherein said step of determining the red blood cell character of said site comprises characterizing the red blood cell flux of said site.

88. The method according to claim 84 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises employing Doppler flowmetry techniques.

89. The method according to claim 84 ,wherein said step of determining the type of physiological fluid at said site comprises characterizing the pulse of said site.

90. The method according to claim 89 , wherein the step of characterizing the pulse of said site comprises characterizing the red blood cell character of said site.

91. The method according to claim 90 , wherein the step of characterizing the red blood cell character of said site comprises characterizing the red blood cell flux of said site.

92. The method according to claim 84 , wherein said step of determining the type of physiological fluid at said site comprises characterizing the hemoglobin character of said physiological fluid at said site.

93. The method according to claim 92 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the hemoglobin concentration of said physiological fluid at said site.

94. The method according to claim 92 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the concentration of the oxygenated hemoglobin and deoxygenated hemoglobin of physiological fluid at said site.

95. The method according to claim 92 , wherein the step of characterizing the hemoglobin character of said physiological fluid at said site comprises determining the oxygenated hemoglobin to deoxygenated hemoglobin ration of said physiological fluid at said site.

96. The method according to claim 84 , further comprising the step of accessing said physiological fluid at said suitable sampling site.

97. The method according to claim 84 , further comprising the step of stimulating the site to enhance the volume of fluid expressed from said site.

98. The method according to claim 84 , further comprising the step of determining the concentration of at least one analyte in said physiological sample.

99. The method according to claim 98 , wherein said concentration determination comprises transferring said physiological sample to an analyte concentration test strip.

100. The method according to claim 98 , wherein said at least one analyte is glucose and said physiological sample is blood.

101. The method according to claim 98 , wherein said at least one analyte is glucose and said physiological sample is interstitial fluid.

102. The method according to claim 98 , wherein an automated meter performs said concentration determination automatically.

103. The method according to claim 84 , wherein said step of measuring the flow rate of said physiological fluid at said potentially suitable site comprises characterizing the temperature of said physiological fluid at said potentially suitable site.

104. A kit for determining the analyte concentration of a physiological sample, said kit comprising:

a plurality of devices selected from the group consisting of:

a plurality of devices according to claim 1 ,

ii. a plurality of devices according to claim 15 , and

iii. a plurality of devices according to claim 34 .

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2002
From: MATZINGER, DAVID; QURAISHI, KHALID R.
To: LIFESCAN, INC.
Reel/Frame 012660/0518 →
Continuity (1)
Related Publication 20030069509A1 · Apr 10, 2003